Parsifal Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$120M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
+$60.1M |
| 3 |
Cigna
CI
|
+$54.6M |
| 4 |
SharkNinja
SN
|
+$53.2M |
| 5 |
American Water Works
AWK
|
+$42.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutanix
NTNX
|
+$59.1M |
| 2 |
New York Times
NYT
|
+$58.4M |
| 3 |
TKO Group
TKO
|
+$49.9M |
| 4 |
Burlington
BURL
|
+$11.3M |
| 5 |
AerCap
AER
|
+$8.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 41.15% |
| 2 | Consumer Staples | 21.13% |
| 3 | Industrials | 11.81% |
| 4 | Healthcare | 11.12% |
| 5 | Technology | 7.22% |
Similar funds
Parsifal Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Parsifal Capital Management held 22 positions worth $1.46B, down 15% from $1.71B the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Parsifal Capital Management withdrew a net $357M in Q4 2023, closing 3 positions and reducing 9 holdings. Its most notable exit was New York Times, an estimated $58.4M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 41% of assets, up from 28% a quarter earlier, followed by Consumer Staples and Industrials.
Against the trend, Parsifal Capital Management opened a new position in Clorox worth $128M.
- Parsifal Capital Management's largest Q4 2023 buy was Clorox: 899,400 shares worth $128M.
- Parsifal Capital Management added most to SharkNinja in Q4 2023, an estimated $53.2M increase.
- Parsifal Capital Management's biggest Q4 2023 reduction was Nutanix, cutting an estimated $59.1M.
- Parsifal Capital Management fully exited New York Times in Q4 2023, selling an estimated $58.4M.
- Parsifal Capital Management's ten largest holdings make up 75% of its $1.46B portfolio in Q4 2023.
- Parsifal Capital Management opened 5 new positions and closed 3 in Q4 2023.
- Parsifal Capital Management's portfolio value fell 15% quarter-over-quarter to $1.46B.
Based on Parsifal Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.